Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1995
10/19/1995WO1995027503A1 Antirestenosis protein
10/19/1995WO1995027502A1 Method of treating auto-immune diseases using type one interferons
10/19/1995WO1995027501A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound
10/19/1995WO1995027500A1 TREATMENT OF AUTOIMMUNE DISEASE USING ORAL TOLERIZATION AND/OR Th2-ENHANCING CYTOKINES
10/19/1995WO1995027499A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon
10/19/1995WO1995027498A1 Use of cyclic depsipeptides with 18 ring atoms
10/19/1995WO1995027497A1 Method of combating mammalian neoplasia, and lytic peptides therefor
10/19/1995WO1995027496A1 Vasoactive intestinal polypeptide
10/19/1995WO1995027495A2 Treatment of partial growth hormone insensitivity syndrome
10/19/1995WO1995027494A1 DEFECTIVE HERPES AND DEFECTIVE ADENO-ASSOCIATED VIRUS VECTORS WITH p53 FOR THE TREATMENT OF CANCER
10/19/1995WO1995027493A1 Pyrimidine deoxyribonucleoside potentiation of combination therapy based on 5-fluorouracil and interferon
10/19/1995WO1995027480A1 Heme-bearing microparticles for targeted delivery of drugs
10/19/1995WO1995024481A3 Humanized monoclonal antibodies against human interleukin-4
10/19/1995WO1995020658A3 Diagnosis and treatment of infections due to streptococci and enterococci
10/19/1995WO1995019433A3 Anti-hepatitis b poly- and oligonucleotides
10/19/1995WO1995018855A3 Synthetic antimicrobial peptides
10/19/1995WO1995017904A3 Botulinum toxins for treating various disorders and associated pain
10/19/1995WO1995006764A3 Oligonucleotides with rna cleavage activity
10/19/1995WO1994028145A3 Expression of urokinase plasminogen activator inhibitors
10/19/1995DE4413023A1 Factor with insulin-like activity from yeast extract
10/19/1995DE4412492A1 Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen The use of cyclic depsipeptides with 18 ring atoms
10/19/1995DE4412372A1 Bovine and human endothelin converting enzymes and corresp. DNA
10/19/1995DE4411425A1 Prepn. of tumour vaccine for active specific immuno-therapy
10/19/1995CA2635998A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method
10/19/1995CA2188675A1 Compositions and methods for gene therapy to treat disease
10/19/1995CA2187635A1 Superoxide dismutase-4
10/19/1995CA2187550A1 Method of treating auto-immune diseases using type one interferons
10/19/1995CA2187360A1 Use of agents which block intercellular adhesion molecule/receptor interaction in the treatment of respiratory viral infection
10/19/1995CA2187345A1 Treatment of autoimmune disease using oral tolerization and/or th2-enhancing cytokines
10/19/1995CA2187336A1 Pharmaceutical formulations for treating japanese cedar pollen allergy
10/19/1995CA2187322A1 Vasoactive intestinal polypeptide
10/19/1995CA2187312A1 Heme-bearing microparticles for targeted delivery of drugs
10/19/1995CA2187299A1 Hepatitis c virus core peptide for stimulation of cytotoxic t lymphocytes and diagnosis of hcv exposure
10/19/1995CA2185353A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon
10/19/1995CA2184617A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound
10/19/1995CA2164723A1 Remedy for diseases characterized by abnormal accumulation or activation of leukocyte
10/19/1995CA2164618A1 Compound ge3
10/19/1995CA2163526A1 Cisplatin resistance gene and uses therefor
10/18/1995EP0677583A1 Bacillus thuringiensis isolate active against dipteran pests
10/18/1995EP0677582A1 Gene transcipts of MHC class I HLA-G and their applications
10/18/1995EP0677533A2 Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof
10/18/1995EP0677532A1 Use of Il-1-antagonists as medicaments for treating diseases with increased Interleukin-6 serum levels
10/18/1995EP0677531A1 Derivates of boronic peptides, preparation and use thereof in therapy
10/18/1995EP0677294A1 Periodontal disease remedy
10/18/1995EP0677292A1 Anti-viral and anti-cancer agents
10/18/1995EP0677115A1 Tia-1 binding proteins and isolated complementary dna encoding the same
10/18/1995EP0677107A1 Clotting inhibitor made from protostomia saliva.
10/18/1995EP0677106A1 Leukocyte derived growth factors
10/18/1995EP0677105A1 Allergenic proteins and peptides from dog dander and uses therefor
10/18/1995EP0677104A1 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use
10/18/1995EP0677101A1 Peptides representing epitopic sites for bacterial and viral meningitis causing agents and their cns carrier, antibodies thereto, and uses thereof
10/18/1995EP0677063A1 A NEW CLASS OF RPTPases: THEIR STRUCTURAL DOMAINS AND LIGANDS
10/18/1995EP0677062A1 Derivatized calcitonins
10/18/1995EP0677061A1 Polypeptide and anti-hiv agent prepared therefrom
10/18/1995EP0677060A1 Peptide inhibitors of cell adhesion
10/18/1995EP0677059A1 Endothelin converting enzyme inhibitors
10/18/1995EP0677057A1 Biopolymer synthesis utilizing surface activated, organic polymers
10/18/1995EP0677043A1 Platelet aggregation inhibiting compounds
10/18/1995EP0676966A1 Antibodies directed against binding-associated epitopes
10/18/1995EP0676965A1 Compounds having reduced immunogenicity and a method of reducing the immunogenicity of compounds
10/18/1995EP0676964A1 Nitrosylation of protein sh groups and amino acid residues as a therapeutic modality
10/18/1995EP0676955A1 Red blood cell surrogate
10/18/1995EP0676954A1 Human immunodeficiency virus decoy
10/18/1995EP0676949A1 Anticaries compositions
10/18/1995EP0596935B1 Antiviral pharmaceutical compositions for vaginal administration
10/18/1995EP0569393B1 Derivatives of dicarboxylic acids having six to twelve carbon atoms and use of these derivatives and dicarboxylic acids alone in the preparation of pharmaceutical compositions for enteral and parenteral nutrition
10/18/1995CN1110323A Novel polypeptides and DNAS encoding them
10/18/1995CN1110279A Method for extracting albumen from animal's blood by precipitating method
10/18/1995CN1110178A Superoxide dismutase capsule and preparation method thereof
10/17/1995US5459255 For incorporation into oligonucleotides, cleaving RNA site specifically
10/17/1995US5459250 Truncated mammalian growth factor DNA sequence
10/17/1995US5459240 Genetic engineering of proteins
10/17/1995US5459238 Stimulate cytototoxic T lymphocyte immunity by interacting with human leucocyte antigen; possible AIDS vaccine
10/17/1995US5459237 Peptide compositions and uses therefor
10/17/1995US5459236 Vasoactive vasotocin derivatives
10/17/1995US5459235 Antimicrobial peptides antibodies and nucleic acid molecules from bovine neutrophils
10/17/1995US5459128 Restenosis inhibitors
10/17/1995US5459126 Method for decreasing calcium uptake by cells using selected polycations
10/17/1995US5459068 Polymorphonuclear leukocytes, measuring chloride secretion of intestinal epithelial cells, detecting presence of short circuit current
10/17/1995US5459063 Antimalarial agents
10/17/1995US5459060 Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1)
10/17/1995US5459057 Treatment with sphignosine or its analog
10/17/1995US5459051 Genetic engineering, gene expression
10/17/1995US5459049 Gastrointestinal disorders
10/17/1995US5459048 DNA encoding 85kd polypeptide useful in diagnosis of Mycoplasma infections in animals
10/17/1995US5459047 BMP-6 proteins
10/17/1995US5459036 Extracellular signal-regulated kinase, sequences, and methods of production and use
10/17/1995US5458878 P. exotoxin fusio proteins have COOHG220101al alterations which increase cytotoxicity
10/17/1995US5458876 Control of microbial growth with lantibiotic/lysozyme formulations
10/17/1995US5458874 Method of increasing monocyte chemotaxis with CAP37 and monocyte chemotactic portions thereof
10/17/1995CA2001671C Aqueous elcatonin solution composition
10/17/1995CA1337372C Inhibition of bacterial ribonucleotide reductase
10/17/1995CA1337333C Legionellosis vaccines and methods for their production
10/17/1995CA1337332C Influenza vaccine and novel adjuvants
10/17/1995CA1337330C Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components
10/13/1995CA2146833A1 Boronic peptides derivatives; process for preparing the same and their use as therapeutic agents
10/12/1995WO1995027202A1 Screening method using the rzr receptor family
10/12/1995WO1995027074A1 Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
10/12/1995WO1995027071A2 An adenovirus supervector system
10/12/1995WO1995027070A1 Dna expression vectors for use in the treatment of vascular diseases by gene therapy
1 ... 2822 2823 2824 2825 2826 2827 2828 2829 2830 2831 2832 2833 2834 2835 2836 2837 2838 2839 2840 2841 2842 ... 3163